Original Research
Published on 22 Jul 2022
Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers
in Drugs Outcomes Research and Policies
- 3,444 views
- 5 citations












